AzTrials
AzTrials

Medical StudentNCT06945159

AI-Assisted Learning in Medicine

An observational study of Medical Student, run by Kang Zhang at 2 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This multi-center retrospective cohort study investigates the real-world impact of integrating MetaGP-Edu, a proprietary AI tool fine-tuned for medical education, into the undergraduate Internal Medicine curriculum. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Medical Student
How many people
1,632 participants
Where
2 sitesChina
Study dates
1 Jun 2020to 1 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: The study population comprises undergraduate medical students who completed the mandatory Internal Medicine curriculum at several major academic medical centers in China over multiple specified academic years. Inclusion in this retrospective analysis was determined by the availability of complete, official academic records for the relevant course during the defined time periods covering both before and after the implementation of the MetaGP-Edu tool.

Who may be able to join

  • Inclusion criteria required students to have completed the entire Internal Medicine course and possess a recorded final numeric score for the course within the selected timeframe

Who cannot join

  • Students with incomplete academic records for the course, those who transferred between institutions mid-course, or individuals identified as having repeated the course were excluded

Trial locations and contacts

2 sites in 1 country.

China2 sites
  • Peking Union Medical College

    Beijing

  • Peking University Health Science Center

    Beijing

Other trials in China

About this study

Official title: Impact of Supplementary Access to a Fine-Tuned Medical Large Language Model (MetaGP-Edu) on Learning Outcomes in Undergraduate Medicine Education

This multi-center retrospective cohort study investigates the real-world impact of integrating MetaGP-Edu, a proprietary AI tool fine-tuned for medical education, into the undergraduate Internal Medicine curriculum. Utilizing historical academic records from several major medical institutions in China across multiple academic years, the study compares the performance of student cohorts who learned via traditional methods only with subsequent cohorts who had supplementary access to MetaGP-Edu. The primary outcome measure is overall academic performance in the Internal Medicine course, assessed through final course scores. The analysis aims to determine if access to the AI tool as a supplementary resource is associated with differences in learning outcomes, while statistically accounting for baseline student characteristics and other potential confounders between the compared cohorts.

Read the detailed description

ackground and Rationale: The effective teaching of Internal Medicine, a cornerstone of undergraduate medical education, presents significant pedagogical challenges due to the breadth and complexity of the subject matter and the large student cohorts typically enrolled in major academic medical centers. While traditional methods like lectures and textbook readings are essential, there is a recognized need for innovative approaches that can better support the development of clinical reasoning, facilitate deeper engagement with complex case material, and offer more personalized learning opportunities at scale. Artificial intelligence (AI), particularly advanced large language models (LLMs) trained on domain-specific knowledge, holds considerable potential as an educational technology to address these needs. MetaGP-Edu, a proprietary generative foundation model fine-tuned specifically for medical education using pedagogical datasets, was developed to explore this potential by serving as a supplementary learning resource. Evaluating the real-world impact of integrating such tools into established curricula is crucial for evidence-informed educational practice.

Objectives: The primary objective of this study is to retrospectively evaluate the association between the availability of the MetaGP-Edu AI tool as a supplementary learning resource and overall student academic performance in the core Internal Medicine curriculum.

Study Design: This investigation employs a multi-center, retrospective cohort study design. Routinely collected academic data from several major medical schools in China over multiple consecutive academic years will be analyzed. This approach allows for the comparison of student cohorts based on their historical exposure to different educational resource environments (with vs. without MetaGP-Edu access) within real-world academic settings.

Setting and Participants: The study encompasses data from undergraduate medical students enrolled in the mandatory Internal Medicine course at several large, academically affiliated medical institutions in China. Participants include students who completed the course across a span of academic years covering the period before and after the introduction of MetaGP-Edu (approximately Fall 2022). Inclusion is based on the availability of complete academic records for the Internal Medicine course during the specified study period.

Exposure/Intervention and Comparator: The study compares two main cohorts defined by the timing of MetaGP-Edu availability:

Comparator Cohort (Pre-MetaGP-Edu): Students who completed the Internal Medicine course in the academic years prior to the introduction of MetaGP-Edu. These students utilized the institutions' established traditional teaching methods (e.g., lectures, tutorials, standard case discussions, textbook assignments) without access to the MetaGP-Edu tool.

Exposure Cohort (Post-MetaGP-Edu): Students who completed the Internal Medicine course in the academic years following the introduction of MetaGP-Edu. These students participated in the same core traditional curriculum components but also had access to MetaGP-Edu via institutional platforms as a supplementary, optional resource for self-directed learning, case exploration, and clinical query support.

Outcome Measures: The primary outcome measure is overall academic performance in the Internal Medicine course, typically represented by the final numeric course score (e.g., on a 0-100 scale) as documented in official university records. Key covariates, including measures of baseline academic achievement (e.g., prior cumulative GPA or equivalent), demographic factors (e.g., sex), and institutional site, will be extracted from administrative data to allow for statistical adjustment.

Conditions
Medical Student
Keywords
artificial intelligence, MetaGP-Edu, Large Language Model, Education

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06945159
Study groupRoleWhat they receive
Pre-MetaGP-Edu CohortsThis group includes all students who completed the Internal Medicine course at the six participating institutions during the academic years prior to 2022 (2020-2021 and 2021-2022). These students learned exclusively through the traditional curriculum methods described above, without access to the MetaGP tool.
Post-MetaGP-Edu CohortsThis group includes all students who completed the Internal Medicine course starting from the 2022 academic year onwards (2022-2023 and 2023-2024). These students experienced the same core traditional curriculum components but also had access to MetaGP- as a supplementary learning resource throughout their course duration.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. academic performance

    The primary outcome measure was student academic performance in the Internal Medicine course, operationalized as the final numeric course score (scaled 0-100) obtained from official university transcripts

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2025
  2. Study start1 Jun 2020
  3. Primary completion1 Dec 2024
  4. Study completion1 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
1,632 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06945159
Sponsor's protocol ID
AI and medical education
Status last verified
Apr 2025
First submitted
18 Apr 2025
Last updated
25 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Medical Student, run by Kang Zhang at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

academic performance (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in